DXCM vs OLN · P/E 63, rev $4.03B vs rev $6.54B
DexCom Inc (DXCM) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. OLN currently screens at market cap $2.62B.
Not investment advice. Open the DXCM and OLN stock pages for the full models.
Not investment advice.